BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8565112)

  • 1. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein.
    Dzeletovic S; Babiker A; Lund E; Diczfalusy U
    Chem Phys Lipids; 1995 Nov; 78(2):119-28. PubMed ID: 8565112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major differences in oxysterol formation in human low density lipoproteins (LDLs) oxidized by *OH/O2*- free radicals or by copper.
    Zarev S; Thérond P; Bonnefont-Rousselot D; Beaudeux JL; Gardès-Albert M; Legrand A
    FEBS Lett; 1999 May; 451(2):103-8. PubMed ID: 10371147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages.
    Brown AJ; Dean RT; Jessup W
    J Lipid Res; 1996 Feb; 37(2):320-35. PubMed ID: 9026530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper.
    Patel RP; Diczfalusy U; Dzeletovic S; Wilson MT; Darley-Usmar VM
    J Lipid Res; 1996 Nov; 37(11):2361-71. PubMed ID: 8978488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oxysterols cholest-5-ene-3 beta,4 alpha-diol, cholest-5-ene-3 beta,4 beta-diol and cholestane-3 beta,5 alpha,6 alpha-triol are formed during in vitro oxidation of low density lipoprotein, and are present in human atherosclerotic plaques.
    Breuer O; Dzeletovic S; Lund E; Diczfalusy U
    Biochim Biophys Acta; 1996 Jul; 1302(2):145-52. PubMed ID: 8695664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper.
    Carpenter KL; Wilkins GM; Fussell B; Ballantine JA; Taylor SE; Mitchinson MJ; Leake DS
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):625-33. PubMed ID: 7999000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of human low-density lipoprotein by soybean 15-lipoxygenase in combination with copper (II) or met-myoglobin.
    O'Leary VJ; Graham A; Stone D; Darley-Usmar VM
    Free Radic Biol Med; 1996; 20(4):525-32. PubMed ID: 8904293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THP1 macrophages oxidized cholesterol, generating 7-derivative oxysterols specifically released by HDL.
    Chen Y; Arnal-Levron M; Lagarde M; Moulin P; Luquain-Costaz C; Delton I
    Steroids; 2015 Jul; 99(Pt B):212-8. PubMed ID: 25742736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of myeloperoxidase/nitrite-oxidized low-density lipoprotein toward endothelial cells is due to a high 7beta-hydroxycholesterol to 7-ketocholesterol ratio.
    Steffen Y; Wiswedel I; Peter D; Schewe T; Sies H
    Free Radic Biol Med; 2006 Oct; 41(7):1139-50. PubMed ID: 16962939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous transfer of phospholipid and cholesterol hydroperoxides between cell membranes and low-density lipoprotein: assessment of reaction kinetics and prooxidant effects.
    Vila A; Korytowski W; Girotti AW
    Biochemistry; 2002 Nov; 41(46):13705-16. PubMed ID: 12427033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary oxysterols are incorporated in plasma triglyceride-rich lipoproteins, increase their susceptibility to oxidation and increase aortic cholesterol concentration of rabbits.
    Vine DF; Mamo CL; Beilin LJ; Mori TA; Croft KD
    J Lipid Res; 1998 Oct; 39(10):1995-2004. PubMed ID: 9788246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxysterols from oxidized LDL are cytotoxic but fail to induce hsp70 expression in endothelial cells.
    Pirillo A; Zhu W; Roma P; Galli G; Caruso D; Pellegatta F; Catapano AL
    FEBS Lett; 1999 Nov; 462(1-2):113-6. PubMed ID: 10580102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives.
    Rubbo H; Parthasarathy S; Barnes S; Kirk M; Kalyanaraman B; Freeman BA
    Arch Biochem Biophys; 1995 Dec; 324(1):15-25. PubMed ID: 7503550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varying susceptibility of different low density lipoproteins to oxidative modification.
    Jialal I; Freeman DA; Grundy SM
    Arterioscler Thromb; 1991; 11(3):482-8. PubMed ID: 2029490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC.
    Kritharides L; Jessup W; Gifford J; Dean RT
    Anal Biochem; 1993 Aug; 213(1):79-89. PubMed ID: 8238886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.
    Bagnati M; Perugini C; Cau C; Bordone R; Albano E; Bellomo G
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):143-52. PubMed ID: 10229669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative degradation of cholesteryl esters in low-density lipoproteins: analysis by liquid chromatography-light scattering and protection by a new synthetic antioxidant, S20478.
    Arborati M; Benchorba D; Lesieur I; Bizot-Espiard JG; Guardiola-Lemaitre B; Chapman MJ; Ninio E
    Fundam Clin Pharmacol; 1997; 11(1):68-77. PubMed ID: 9182079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro.
    Schlotte V; Sevanian A; Hochstein P; Weithmann KU
    Free Radic Biol Med; 1998 Nov; 25(7):839-47. PubMed ID: 9823550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein.
    Chang YH; Abdalla DS; Sevanian A
    Free Radic Biol Med; 1997; 23(2):202-14. PubMed ID: 9199882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway.
    Christen S; Thomas SR; Garner B; Stocker R
    J Clin Invest; 1994 May; 93(5):2149-58. PubMed ID: 8182147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.